Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

MAZEMAZE
6 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in MAZE THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 321,227 shares of MAZE (MAZE THERAPEUTICS INC), worth $9.6M as of 2026-Q2. The position was increased (+64.7% shares). MAZE represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$9.6M

Current Shares

321,227

Total Value Change

+$9.5M

Total Shares Change

+316,900

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
321,227
+64.7%
$9.6M0.0%$29.84
40
2026-Q1
Increased
195,084
+961.3%
$5.8M0.0%$44.18
44
2025-Q4
Increased
18,381
+92.0%
$761,5240.0%$40.05
39
2025-Q3
Increased
9,574
+65.6%
$248,2540.0%$25.20
23
2025-Q2
Increased
5,782
+33.6%
$70,9460.0%$12.13
19
2025-Q1
New
4,327
-
$47,6400.0%$11.42
31

Other major holders of MAZE: Janus Henderson Group Ltd., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used